Medical News

---

• Work, social, or family life disability affects half of bipolar patients
• Specific metabolic abnormalities associated with schizophrenia
• Statin pretreatment improves outcomes after ischemic stroke
• Cardiac glycoside could reduce prostate cancer risk
• Statin pretreatment improves outcomes after ischemic stroke
• SNP influences serum lipid levels by modulating APOB expression
• Genetic variants impact on age-related postload glucose changes
• Increased 25-hydroxyvitamin D levels linked with decreased diabetes risk
• ISAR-CABG: Drug-eluting stents preferable in saphenous graft lesions
• RAPS: Radial artery offers long-term patency and graft disease benefits in CABG surgery
• Myocardial viability fails to identify patients who will benefit from CABG
• CABG fails to cut ischemic HF mortality but reduces CV mortality, morbidity

Work, social, or family life disability affects half of bipolar patients Posted: 06 Apr 2011 05:00 PM PDT Results from a Spanish study suggest that more than half of bipolar disorder patients experience some degree of disability in their work, social, or family life.

Specific metabolic abnormalities associated with schizophrenia Posted: 06 Apr 2011 05:00 PM PDT Schizophrenia patients exhibit specific metabolic abnormalities related to glucoregulatory processes and proline metabolism, Finnish researchers have found.

Statin pretreatment improves outcomes after ischemic stroke Posted: 05 Apr 2011 05:00 PM PDT Pretreatment with statins is associated with improved functional outcomes in patients with acute ischemic stroke, say researchers.

Cardiac glycoside could reduce prostate cancer risk Posted: 05 Apr 2011 05:00 PM PDT The cardiac glycoside digoxin could be used as prostate cancer-prevention therapy, says a transdisciplinary team of researchers that evaluated the association between existing, tested, nonchemotherapy drugs and their effects on prostate cancer.

Statin pretreatment improves outcomes after ischemic stroke Posted: 05 Apr 2011 05:00 PM PDT Pretreatment with statins is associated with improved functional outcomes in patients with acute ischemic stroke, say researchers.

SNP influences serum lipid levels by modulating APOB expression Posted: 05 Apr 2011 05:00 PM PDT A single-nucleotide polymorphism in the apolipoprotein B gene region significantly influences serum levels of apolipoprotein B and apolipoprotein B-containing lipid particles, show study results.

Genetic variants impact on age-related postload glucose changes Posted: 05 Apr 2011 05:00 PM PDT Common genetic variants linked with postload glucose levels contribute to rises that occur with age, but this is not the case for variants connected with fasting glucose levels, researchers claim.

Increased 25-hydroxyvitamin D levels linked with decreased diabetes risk Posted: 05 Apr 2011 05:00 PM PDT A measure of the amount of vitamin D in the body is inversely associated with the risk for developing Type 2 diabetes in adults, research indicates.

ISAR-CABG: Drug-eluting stents preferable in saphenous graft lesions Posted: 05 Apr 2011 05:00 PM PDT Drug-eluting stents are superior to bare metal stents in the treatment of saphenous vein graft stenosis, and halve the need for repeat revascularizations, 12-month data from the ISAR-GABG trial indicate.

RAPS: Radial artery offers long-term patency and graft disease benefits in CABG surgery Posted: 05 Apr 2011 05:00 PM PDT Using radial arteries to perform coronary artery bypass graft surgery is associated with significant improvements in patency and reductions in graft disease compared with saphenous vein grafts, 5-year results from the RAPS study show.

Myocardial viability fails to identify patients who will benefit from CABG Posted: 05 Apr 2011 05:00 PM PDT Assessing myocardial viability does not identify patients with a differential survival benefit from coronary artery bypass graft surgery plus intensive medical therapy as compared with IMT alone, the STICH Viability substudy has found.

CABG fails to cut ischemic HF mortality but reduces CV mortality, morbidity Posted: 05 Apr 2011 05:00 PM PDT Coronary artery bypass graft surgery does not reduce all-cause mortality in optimally medically treated patients with heart failure and coronary artery disease, but it significantly reduces cardiovascular-related hospitalization and mortality, the STICH trial has found.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610